Melatonin in medically ill patients with insomnia: A double-blind, placebo-controlled study

Journal of Clinical Psychiatry

Volumn 62, Issue 1, 2001, Pages 41-45

  Andrade, C ^a   Srihari, B S ^a   Reddy, K P ^a   Chandramma, L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; HYPNOTIC AGENT; MELATONIN; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; HANGOVER; HUMAN; INSOMNIA; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP INDUCTION; SLEEP PATTERN; SLEEP TIME;

EID: 0035128561     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n0109     Document Type: Article

References (16)

1. Use of melatonin for sleep and circadian rhythm disorders
2. Efficacy of melatonin treatment in jet lag, shift work, and blindness
3. Sleep disorders and melatonin rhythms in elderly people
4. Improvement of sleep quality in elderly people by controlled-release melatonin
5. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: Assessment in a clinical trial of melatonin replacement
6. Melatonin for the treatment of sleep disturbances in major depressive disorder
7. Facilitation of benzodiazepine withdrawal by melatonin
8. Low dose melatonin improves sleep in healthy middle-aged subjects
9. Randomized clinical trial of melatonin after night-shift work: Efficacy and neuropsychologic effects
10. Melatonin and insomnia
11. Melatonin in humans
12. Sleep-promoting effects of melatonin: At what dose, in whom, under what conditions, and by what mechanisms?
13. Melatonin: Therapeutic use in sleep disorders
14. Melatonin: A clinical perspective
15. Psychopharmacology
16. Pro-convulsant effects of oral melatonin in neurologically disabled children